Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cardiac Output Monitoring by ccNexfin© in Pregnant Women

NCT: NCT03735043 · COMPLETED

NCT IDNCT03735043
StatusCOMPLETED
Start Date2019-07-02
Completion2020-06-01

Brief Summary

Variations of cardiac output are frequent in pregnant women during obstetrical procedures, and may participate to poor foetal outcomes through decrease of uteroplacental bloodflow. Thus, monitoring maternal cardiac output appears of major interest, as it would open the way to early initiation of hemodynamic supportive management. The ccNexfin© is a non-invasive hemodynamic monitoring device, whose relevance for continuous monitoring of cardiac output has been reported in a non-pregnant population. The hypothesis is that ccNexfin© gives acceptable measurement of maternal cardiac output in pregnant women.

Frequently Asked Questions

What is Cardiac Output Monitoring by ccNexfin© in Pregnant Women?

Cardiac Output Monitoring by ccNexfin© in Pregnant Women is a clinical trial registered under NCT03735043. Current status: COMPLETED.

What is the status of NCT03735043?

The current status of NCT03735043 (Cardiac Output Monitoring by ccNexfin© in Pregnant Women) is: COMPLETED.

When did Cardiac Output Monitoring by ccNexfin© in Pregnant Women start?

Cardiac Output Monitoring by ccNexfin© in Pregnant Women started on 2019-07-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.